Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in

AngioDynamics Inc
XBER:UG2

Watchlist Manager
AngioDynamics Inc Logo
AngioDynamics Inc
XBER:UG2
Watchlist
Price: 10.8 EUR Market Closed
Market Cap: €1.7B
Write Note Create Alert Ask AI

Wall St Price Targets

UG2 Price Targets Summary
AngioDynamics Inc

Wall Street analysts forecast UG2 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for UG2 is 15.13 EUR with a low forecast of 12.84 EUR and a high forecast of 20.03 EUR.

UG2 Lowest Forecast
Wall Street Target
€12.84
19% Upside
UG2 Average Forecast
Wall Street Target
€15.13
40% Upside
UG2 Highest Forecast
Wall Street Target
€20.03
85% Upside
Lowest Forecast
Price Target
12.84 EUR
19% Upside
Average Forecast
Price Target
15.13 EUR
40% Upside
Highest Forecast
Price Target
20.03 EUR
85% Upside
AngioDynamics Inc Competitors:
Price Targets
ENTX
Entera Bio Ltd
348% Upside
H2A
H2APEX Group SCA
249% Upside
GWH
ESS Tech Inc
172% Upside
ENTX
Entera Bio Ltd
348% Upside
H2A
H2APEX Group SCA
249% Upside
GWH
ESS Tech Inc
172% Upside

Revenue
Forecast

3% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
3% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 14 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 5 years is 7%.

What are analyst estimates?

Gross Profit
Forecast

2% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
2% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 14 years, the compound annual growth rate for Gross Profit has been 2%. The projected CAGR for the next 5 years is 7%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-44%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-44%
Average Miss

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss

What are analyst estimates?

Continue UG2 Research

Summary
UG2 intrinsic value, competitors valuation, and company profile.
DCF Valuation
UG2 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
UG2 stock valuation using valuation multiples.
Wall St Estimates
UG2 price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
UG2 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other AngioDynamics Inc listings:
NASDAQ • USD
ANGO
 F • EUR
UG2
 SWB • EUR
UG2
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is UG2's stock price target?
Price Target
15.13 EUR

According to Wall Street analysts, the average 1-year price target for UG2 is 15.13 EUR with a low forecast of 12.84 EUR and a high forecast of 20.03 EUR.

What is the Revenue forecast for AngioDynamics Inc?
Projected CAGR
7%

Over the last 14 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 5 years is 7%.

What is the Gross Profit forecast for AngioDynamics Inc?
Projected CAGR
7%

Over the last 14 years, the compound annual growth rate for Gross Profit has been 2%. The projected CAGR for the next 5 years is 7%.

Back to Top
ALPHA SPREAD
Follow us
Join 349,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett